検索結果

Company Profile | About Senju | SENJU Pharmaceutical

6-0406 Date of Incorporation April 9, 1947 Capital 1,415,500,000 yen Board of Directors Chairman of the BoardYukoh Yoshida President ＆ CEOShuhei Yoshida Chief Operating OfficerTakeshi Sugisawa Managin...

Quality Policies | About Senju | SENJU Pharmaceutical

We will set the following "Quality Policies" and continue to be a "Good Company" by encouraging cooperation among all employees and providing high-quality products for "realiz...

インフルエンザ菌 10株 アクネ菌 150株 実施方法：連続調査方式 調査対象患者由来の検体から分離された菌株を対象として、アジスロマイシ ンに対する薬剤感受性を測定する。薬剤感受性試験は、CLSI（Clinical and Laboratory Standards Institute）に準じた方法にて実施する。 【実施計画の根拠】 本剤の有効性の主軸となる効能菌に対する抗菌活性は、その使用頻度の...

OTC Products, etc. | Products | SENJU Pharmaceutical

Inquiries are not accepted in a language other than Japanese in principle. Please kindly understand the situation that the inquiries by telephone must use Japanese only. Translated from the Japanese p...

Mytear EYETECT | OTC Products, etc. | Products | SENJU Pharmaceutical

ines Mytear® EYETECT® For teary eye, foreign body sensation CHARACTERISTICS Mytear EYETECT includes the anti-inflammatory ingredient, pranoprofen [swich OTC Drug], and is effective for teary eye, fore...